This is a preview of subscription content, log in via an institution to check access.
Reference
Langan EA, et al. Intralesional interleukin-2: A novel option to maximize response to systemic immune checkpoint therapy in loco-regional metastatic melanoma. Dermatologic Therapy 32: No. 3, May-Jun 2019. Available from: URL: http://doi.org/10.1111/dth.12901 - Germany
Rights and permissions
About this article
Cite this article
Aldesleukin. Reactions Weekly 1762, 24 (2019). https://doi.org/10.1007/s40278-019-64763-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-64763-x